MannKind Corp Sustainability Reports
MannKind Corporation is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 213800GFBCNY1ZFST722
FIGI: BBG001SLLLY3
23 reports from 2004 to 2025
